###begin article-title 0
###xml 31 43 31 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*15 </italic>
###xml 47 55 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*09 </italic>
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*09 </italic>
Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 86 106 86 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium leprae</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 86 106 <span type="species:ncbi:1769">Mycobacterium leprae</span>
Human leukocyte antigens (HLAs) have been proposed to modulate the immune response to Mycobacterium leprae. The association of HLA-DRB1 with leprosy has been reported in several populations, but not in a Chinese population.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 165 173 <span type="species:ncbi:9606">patients</span>
The polymerase chain reaction-sequence-specific oligonucleotide probe with Luminex100 (PCR-SSOP-Luminex) method was used to genotype HLA-DRB1 alleles in 305 leprosy patients and 527 healthy control individuals.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 174 182 <span type="species:ncbi:9606">patients</span>
The HLA-DRB1*15 allele was significantly more prevalent among leprosy patients than healthy controls, whereas the frequency of the HLA-DRB1*09 allele was lower among leprosy patients, especially those with early-onset disease.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 182 190 <span type="species:ncbi:9606">patients</span>
HLA-DRB1 alleles are associated with leprosy susceptibility in a Chinese population. The HLA-DRB1*09 allele was found to be protective exclusively in a subset of early-onset leprosy patients.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 161 181 161 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium leprae</italic>
###xml 318 327 318 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 648 649 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 161 181 <span type="species:ncbi:1769">Mycobacterium leprae</span>
###xml 318 327 <span type="species:ncbi:1769">M. leprae</span>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
###xml 481 489 <span type="species:ncbi:9606">patients</span>
###xml 609 617 <span type="species:ncbi:9606">patients</span>
Leprosy is a chronic infectious disease that occurs in genetically predisposed individuals. It is caused by infection with the intracellular macrophage pathogen Mycobacterium leprae. Leprosy is characterized by a spectrum of disease symptoms that result from interactions between the host immune response and invading M. leprae. At the lepromatous extreme, patients exhibit multibacillary infection and an absence of antigen-specific cellular immunity. At the tuberculoid extreme, patients exhibit paucibacillary infection and a strong cellular immune response. Between these two extremes, borderline leprosy patients show intermediate phenotypes [1].
###end p 10
###begin p 11
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
Leprosy was once prevalent worldwide. However, there has been a steady decline in the prevalence of leprosy since the introduction of multidrug therapy by the World Health Organization (WHO-MDT) in 1982 [2]. The detection rate of new cases, however, remains steady in some countries, including several regions of China [3,4]. Since 2002, nearly 1,600 new cases have been detected annually in China [4].
###end p 11
###begin p 12
###xml 96 106 96 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae </italic>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 385 392 385 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR </italic>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 512 520 512 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR2 </italic>
###xml 528 554 528 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*15, *16 *04, *10 </italic>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*12 </italic>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 712 720 712 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR3 </italic>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 892 899 892 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR </italic>
###xml 982 989 982 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR </italic>
###xml 96 105 <span type="species:ncbi:1769">M. leprae</span>
###xml 668 677 <span type="species:ncbi:442169">Argentine</span>
Previous studies have suggested a strong influence of genetic factors in regulation of the anti-M. leprae immune response [5,6]. Two recent genome-wide linkage analyses have identified chromosome 6p21 as a major leprosy-susceptibility locus [7,8]. This region harbors the HLA gene cluster, which has been extensively studied for its role in leprosy pathogenesis [9-12]. In particular, HLA-DR alleles have been consistently found to be associated with leprosy [13]. Several studies reported an association of the HLA-DR2 alleles HLA-DRB1*15, *16 *04, *10 and *12 with susceptibility or resistance to leprosy in Brazilian, Vietnamese, South Indian, Indonesian, Thai and Argentine populations [14-18]. In addition, HLA-DR3 alleles were also found to be associated with leprosy susceptibility in Surinamese and Mexican populations [19,20]. These studies have not only shown the importance of the HLA-DR locus in leprosy susceptibility, but have also highlighted the fact that different HLA-DR alleles are associated with leprosy in different populations.
###end p 12
###begin p 13
###xml 287 296 287 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 492 501 492 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 528 533 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1 </italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1 </italic>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
Although leprosy remains a major public health concern and one of the infectious diseases most capable of causing disability in China, the genetic susceptibility to leprosy in Chinese populations has received little study. The only such report was an investigation of the association of HLA-DRB1 with leprosy in Southern China; however, due to the small sample used, this study failed to detect this well-established association [21]. In the current study, we investigated the association of HLA-DRB1 with leprosy by genotyping DRB1 alleles in a large Chinese Han sample of 305 leprosy patients and 527 healthy control individuals. We further investigated the association of DRB1 alleles with clinical subtype and age-of-onset of the disease.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and controls
###end title 15
###begin p 16
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 862 863 862 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
###xml 407 414 <span type="species:ncbi:9606">patient</span>
###xml 448 456 <span type="species:ncbi:9606">patients</span>
###xml 634 642 <span type="species:ncbi:9606">patients</span>
The study included 305 unrelated individuals with a diagnosis of leprosy and 527 control samples. The diagnosis of leprosy was based on clinical assessment and detection of acid-fast bacilli in skin-slit smears and histopathological assessment of skin lesions. The patients were further classified as multibacillary (MB) or paucibacillary (PB) on the basis of clinical and histological criteria [1]. The MB patient subset (n = 179), which included patients with lepromatous leprosy (LL), borderline lepromatous leprosy (BL)and borderline (BB) leprosy, had a bacterial index (BI) > 0. The PB group (n = 126) had a BI = 0, and included patients with borderline tuberculoid leprosy (BT) and tuberculoid leprosy (TT). Control sample donors were recruited from the Shandong Blood Center. Some characteristics of the 305 cases and 527 controls are summarized in Table 1.
###end p 16
###begin p 17
Characteristics of the study population of 305 cases and 527 controls
###end p 17
###begin p 18
NA: no onset age for controls
###end p 18
###begin p 19
All subjects gave informed consent to participate in the study. The protocol was approved by the Ethical Committee of the Shandong Provincial Institute of Dermatovenereology.
###end p 19
###begin title 20
###xml 19 29 19 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1* </italic>
DNA extraction and HLA-DRB1* typing
###end title 20
###begin p 21
Genomic DNA was extracted from peripheral blood using a commercially available DNAzol extraction kit (E.Z.N.A Blood DNA KIT, Omega Bio-tek, Inc).
###end p 21
###begin p 22
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 386 395 386 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 937 947 932 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1* </italic>
The procedure for HLA genotyping by the polymerase chain reaction-sequence-specific oligonucleotide probe with Luminex100 (PCR-SSOP-Luminex) method included PCR amplification, hybridization, a streptavidin-phycoerythrin (SA-PE) reaction, and analytical measurements [22]. Target DNA was amplified by PCR using 5' biotin-labeled primers that were highly specific to certain sequences of HLA-DRB1 genes. PCR was carried out in a 20 muL reaction containing Lifecodes mixture (6 muL), Taq polymerase (0.2 muL), nuclease-free water (11.8 muL) and genomic DNA (3 muL). After denaturization, amplified DNA was allowed to hybridize to complementary DNA probes coupled to microbeads. The oligobead-coupled, hybridized PCR product was labeled with streptavidin-phycoerythrin. The fluorescent intensity of phycoerythrin on each coded oligobead that had hybridized with the biotin-labeled PCR product was measured using a Luminex apparatus, and the HLA-DRB1* genotype was determined with the assistance of Genosearch typing software (Quick-Type for LifeMatch 2.0, Luminex Corporation). This HLA-typing analysis was done at the Shandong blood center.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 373 381 <span type="species:ncbi:9606">patients</span>
###xml 434 442 <span type="species:ncbi:9606">patients</span>
Power calculations, carried out using PS software , showed that our sample size of 305 patients and 527 controls had greater than 95% power to detect an odds ratio (OR) of 2.0 at a significance level of 5% when the frequency of the allele of interest was greater than 0.10. Allele frequencies were calculated by direct counting. The differences in allele frequency between patients and controls and between early onset and late-onset patients were tested using logistic regression analyses with adjustments for age and gender. The significance of the allele frequency difference between the MB and PB cases was analyzed using Pearson Chi-square tests. The nominal P-values were corrected for multiple testing (Pc-value) using the Bonferroni correction (i.e., by multiplying the nominal P-values by the number of HLA alleles being tested). A Pc-value < 0.05 was accepted as statistically significant. The strength of associations was estimated by calculating ORs. Statistical analyses were carried out using SPSS software (version 11.0).
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 45 55 45 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1* </italic>
###xml 161 170 161 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 341 349 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*15 </italic>
###xml 629 641 629 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*09 </italic>
###xml 78 85 <span type="species:ncbi:9606">patient</span>
###xml 297 305 <span type="species:ncbi:9606">patients</span>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
###xml 679 686 <span type="species:ncbi:9606">patient</span>
Table 2 summarizes the allele frequencies of HLA-DRB1* alleles in the leprosy patient and control populations and the results of association analyses. Of the 13 HLA-DRB1 alleles determined by the PCR-SSOP-Luminex method, two alleles showed a significant difference in frequency (P < 0.05) between patients and controls. The frequency of the DRB1*15 allele among patients was 0.32 (195/610), which was significantly higher than the frequency of 0.18 (185/1054) observed in the healthy controls (P < 0.001). This difference remained significant after correcting for multiple testing (Pc < 0.001). In contrast, the frequency of the HLA-DRB1*09 allele was significantly lower in the patient population than among controls (P = 0.002, Pc = 0.026).
###end p 26
###begin p 27
###xml 33 43 33 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1* </italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Allele frequency distribution of HLA-DRB1* in patients versus controls, and MB versus PB forms of leprosy
###end p 27
###begin p 28
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
n, number of individuals; AF, allelic frequency.
###end p 28
###begin p 29
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P-values are from allele-based tests.
###end p 29
###begin p 30
###xml 43 53 43 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1* </italic>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 261 271 261 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1* </italic>
###xml 419 427 417 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*15 </italic>
###xml 508 516 506 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*09 </italic>
###xml 582 583 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
We further investigated the association of HLA-DRB1* alleles with the clinical subtypes of leprosy. No significant differences in the allele frequencies were observed between the MB and PB forms of the disease (Table 2). We then investigated the association of HLA-DRB1* alleles with early-onset (age-at-onset </= 16 years; n = 141) and late-onset (age-at-onset > 16 years; n = 164) leprosy. Interestingly, whereas the DRB1*15 allele was significantly associated with both early- and late-onset leprosy, the DRB1*09 was only significantly associated with early-onset leprosy (Table 3).
###end p 30
###begin p 31
###xml 33 43 33 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1* </italic>
Allele frequency distribution of HLA-DRB1* in early versus late-onset leprosy groups
###end p 31
###begin p 32
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
n, number of individuals; AF, allelic frequency.
###end p 32
###begin p 33
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P-values are from allele-based tests.
###end p 33
###begin p 34
All markers with allele frequency above 0.01 have been tested and were in HW equilibrium.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 50 59 50 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 503 512 503 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 50 59 <span type="species:ncbi:1769">M. leprae</span>
###xml 275 282 <span type="species:ncbi:9606">patient</span>
Leprosy is a chronic infectious disease caused by M. leprae. The disease only occurs in a small percentage (1-3%) of infected individuals [23], an observation that supports the important role of host genetic factors in the development of leprosy. The reported male-to-female patient ratio is 2:1 [24], consistent with the known role of gender as an independent risk factor for leprosy susceptibility. In our study, more male cases were collected than female cases; thus, the observed association of the HLA-DRB1 allele with leprosy was based on a mostly male population.
###end p 36
###begin p 37
###xml 45 53 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DR2 </italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 232 239 232 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">leprae </italic>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 529 539 529 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae </italic>
###xml 229 238 <span type="species:ncbi:1769">M. leprae</span>
###xml 529 538 <span type="species:ncbi:1769">M. leprae</span>
###xml 570 578 <span type="species:ncbi:9606">patients</span>
Many studies have reported an association of HLA-DR2 with leprosy, a linkage that is consistent with the finding that HLA-DR antigens are associated with disease and the suggestion that a majority of restriction determinants for M. leprae reside on DR, and not DP or DQ molecules [25]. A functional study of Ag-specific T-cell responses within the context of HLA-DR has shown that HLA-DR-associated immunity may be crucial in the adaptive immune response to infection [26]. Thus, HLA-DR plays a major role in the presentation of M. leprae antigens to T cells in leprosy patients.
###end p 37
###begin p 38
###xml 121 130 121 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 261 273 261 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*15 </italic>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 411 423 411 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*15 </italic>
###xml 653 665 653 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*09 </italic>
###xml 1066 1068 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 794 802 <span type="species:ncbi:9606">patients</span>
###xml 1046 1054 <span type="species:ncbi:9606">patients</span>
By analyzing a large number of Chinese leprosy patients, our study has provided the first evidence for an association of HLA-DRB1 with leprosy in a Chinese population and provided additional support for the important role of HLA in the pathogenesis of leprosy. HLA-DRB1*15 has been demonstrated to be a leprosy-susceptibility allele among Brazilian [14] and Indian [15] populations. In our study, we found that HLA-DRB1*15 was also associated with an increased risk of leprosy in a Chinese population, and exhibited an allele frequency (32%) similar to that observed in Indian populations (31%) but higher than that observed among Brazilians (15%). The HLA-DRB1*09 allele was found to be associated with protection against leprosy in our study; its frequency was significantly lower in leprosy patients than in controls, and the association remained significant after correcting for multiple testing (P = 0.002, Pc = 0.026). This allele also showed a protective effect against the disease in Southern India, but the allele frequency among Indian patients was 0.017 [15], much lower than that observed in the Chinese population studied here (0.08).
###end p 38
###begin p 39
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 215 225 215 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1* </italic>
###xml 418 430 416 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*09 </italic>
###xml 566 578 564 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*15 </italic>
###xml 879 888 877 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
It has been reported that the HLA lymphotoxin-alpha (LTA)+80 locus within the 6p21 chromosomal region is a major risk factor for early-onset (i.e., < 16 years old) leprosy [27]. To investigate whether the effect of HLA-DRB1* on leprosy risk was age-onset dependent, we stratified leprosy patients into early-onset (</= 16 years) and late-onset (> 16 years) groups in association analyses. Interestingly, we found that HLA-DRB1*09 was associated with protection effect against early-onset leprosy (P = 0.003), but not late-onset leprosy (P = 0.285). In contrast, the HLA-DRB1*15 allele showed no age-onset-dependent effects. To our knowledge, this is the first report that HLA-DRB1*09 has an impact on disease onset. Further studies will be needed to investigate the association of the LTA+80 locus with leprosy in Chinese populations and determine whether the association at the HLA-DRB1 locus is independent of the LTA+80 locus.
###end p 39
###begin p 40
###xml 118 128 118 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae </italic>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 339 348 339 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 466 475 466 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 533 539 533 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 580 589 580 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 118 127 <span type="species:ncbi:1769">M. leprae</span>
###xml 386 393 <span type="species:ncbi:9606">patient</span>
De Vries et al. have proposed a two-step model for the development of leprosy, proposing that successful infection of M. leprae is first established in genetically vulnerable individuals, and subsequent clinical manifestation of the disease is influenced by additional host and environmental factors [28]. In our study, the frequencies of HLA-DRB1 alleles were similar in the MB and PB patient groups. This is consistent with the two-step model, suggesting that the HLA-DRB1 locus may influence the overall susceptibility to leprosy per se. It has also been reported that certain HLA-DRB1 alleles are associated with MB or PB forms of leprosy [29-31], suggesting that HLA-DRB1 may also be involved in the clinical manifestation of the disease.
###end p 40
###begin p 41
###xml 89 98 89 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1 </italic>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 55 62 <span type="species:ncbi:9606">patient</span>
Taken together, our association analysis of stratified patient groups indicates that the HLA-DRB1 locus is largely associated with leprosy per se, and only HLA-DRB1*09 shows an age-onset-dependent effect.
###end p 41
###begin title 42
Conclusion
###end title 42
###begin p 43
###xml 106 119 106 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">the HLA-DRB1 </italic>
###xml 172 183 172 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1*15</italic>
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DRB1*09</italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
In summary, by analyzing a large sample of Chinese Han leprosy patients, our genetic association study of the HLA-DRB1 locus provides strong evidence for an association of HLA-DRB1*15, as a susceptibility allele, and DRB1*09, as a protective allele, with leprosy in a Chinese population. Furthermore, we demonstrate for the first time that HLA-DRB1*09 has an impact on the onset of disease, exerting a protective effect only against early-onset leprosy. These alleles could act alone or in combination with other genes to confer susceptibility or resistance to leprosy in Chinese Han populations.
###end p 43
###begin title 44
Abbreviations
###end title 44
###begin p 45
###xml 5 10 <span type="species:ncbi:9606">human</span>
HLA: human leukocyte antigen; MB: multibacillary; PB: paucibacillary; PCR: polymerase chain reaction; SSOP: sequence-specific oligonucleotide probe.
###end p 45
###begin title 46
Competing interests
###end title 46
###begin p 47
The authors declare that they have no competing interests.
###end p 47
###begin title 48
Authors' contributions
###end title 48
###begin p 49
FZ conceived the study, participated in its design and coordination, and finalized the manuscript. HL performed experiments, collected and analyzed data, and wrote the first draft of the paper. SC was involved in study design and collection of samples. CZ was involved in performing experiments and coordination. CW, HZ, TC DL and XY participated in collecting samples. JL was involved in study design and interpretation of results, and finalized the manuscript. All authors read and approved the final manuscript.
###end p 49
###begin title 50
Pre-publication history
###end title 50
###begin p 51
The pre-publication history for this paper can be accessed here:
###end p 51
###begin p 52

###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
This research was supported by National Natural Science Foundation of China (No. 30771943/C030116).
###end p 54
###begin article-title 55
Classification of leprosy according to immunity. A five-group system
###end article-title 55
###begin article-title 56
Elimination of leprosy as a public health problem: progress and prospects
###end article-title 56
###begin article-title 57
###xml 58 65 <span type="species:ncbi:9606">Peoples</span>
Leprosy control in a prefecture of Yunnan Province in the Peoples' Republic of China, using intensive health education of the public and primary health care workers for the detection of cases, 1998-1999
###end article-title 57
###begin article-title 58
###xml 47 68 47 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium leprae </italic>
###xml 47 67 <span type="species:ncbi:1769">Mycobacterium leprae</span>
Diversity of potential short tandem repeats in Mycobacterium leprae and application for molecular typing
###end article-title 58
###begin article-title 59
The genetic epidemiology of leprosy in a Brazilian population
###end article-title 59
###begin article-title 60
Some remarks on the genetics of leprosy resistance
###end article-title 60
###begin article-title 61
Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians
###end article-title 61
###begin article-title 62
Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population
###end article-title 62
###begin article-title 63
Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy
###end article-title 63
###begin article-title 64
Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy
###end article-title 64
###begin article-title 65
HLA class-II immune response genes and products in leprosy
###end article-title 65
###begin article-title 66
###xml 92 112 <span type="species:ncbi:1769">Mycobacterium leprae</span>
###xml 156 164 <span type="species:ncbi:9606">patients</span>
Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients
###end article-title 66
###begin article-title 67
Genetics of host response in leprosy
###end article-title 67
###begin article-title 68
###xml 125 133 <span type="species:ncbi:9606">patients</span>
HLA-DRB1*04 and DRB1*10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients
###end article-title 68
###begin article-title 69
Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India
###end article-title 69
###begin article-title 70
Leprosy associated with HLA-DR2 and DQw1 in the population of northern Thailand
###end article-title 70
###begin article-title 71
Associations between HLA-DRB1 alleles and leprosy in an Indonesian population
###end article-title 71
###begin article-title 72
Role of HLA-DR and HLA-DQ alleles in multibacillary leprosy and paucibacillary leprosy in the province of Chaco (Argentina)
###end article-title 72
###begin article-title 73
HLA-DR-associated genetic control of the type of leprosy in a population from Surinam
###end article-title 73
###begin article-title 74
Tuberculoid leprosy in Mexicans is associated with HLA-DR3
###end article-title 74
###begin article-title 75
HLA linked with leprosy in southern China: HLA-linked resistance alleles to leprosy
###end article-title 75
###begin article-title 76
High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population
###end article-title 76
###begin article-title 77
Regulation of cell-mediated immunity in lepromatous leprosy
###end article-title 77
###begin article-title 78
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Male-female (sex) differences in leprosy patients in South Eastern Nigeria: female present late for diagnosis and treatment and have higher rates of deformity
###end article-title 78
###begin article-title 79
Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India
###end article-title 79
###begin article-title 80
HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens
###end article-title 80
###begin article-title 81
Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early onset leprosy
###end article-title 81
###begin article-title 82
HLA class II immune response and suppression genes in leprosy
###end article-title 82
###begin article-title 83
Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians
###end article-title 83
###begin article-title 84
HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker
###end article-title 84
###begin article-title 85
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human leukocyte antigen and leprosy: study in northern Louisiana and review
###end article-title 85

